Newamsterdam Pharma Stock Filter Stocks by Fundamentals
| NAMS Stock | 20.84 0.21 1.00% |
NewAmsterdam Pharma fundamentals help investors to digest information that contributes to NewAmsterdam Pharma's financial success or failures. It also enables traders to predict the movement of NewAmsterdam Stock. The fundamental analysis module provides a way to measure NewAmsterdam Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NewAmsterdam Pharma stock.
NewAmsterdam | Shares Owned by Institutions |
NewAmsterdam Pharma ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, NewAmsterdam Pharma's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to NewAmsterdam Pharma's managers, analysts, and investors.Environmental | Governance | Social |
NewAmsterdam Pharma Institutional Holders
Institutional Holdings refers to the ownership stake in NewAmsterdam Pharma that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of NewAmsterdam Pharma's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing NewAmsterdam Pharma's value.| Shares | Polar Capital Holdings Plc | 2024-06-30 | 1 M | Deerfield Management Co | 2024-09-30 | 901.8 K | Gmt Capital Corp | 2024-06-30 | 891.8 K | Avidity Partners Management Lp | 2024-09-30 | 889.7 K | Artal Group S A | 2024-06-30 | 800 K | Pictet Asset Manangement Sa | 2024-06-30 | 683.7 K | Citadel Advisors Llc | 2024-09-30 | 522.5 K | Woodline Partners Lp | 2024-06-30 | 483.4 K | Affinity Asset Advisors, Llc | 2024-09-30 | 472.4 K | Fcpm Iii Services Bv | 2024-09-30 | 11.8 M | Bain Capital Life Sciences Investors, Llc | 2024-09-30 | 10.5 M |
NewAmsterdam Fundamentals
| Return On Equity | -0.47 | ||||
| Return On Asset | -0.29 | ||||
| Operating Margin | (0.86) % | ||||
| Current Valuation | 1.52 B | ||||
| Shares Outstanding | 92.39 M | ||||
| Shares Owned By Insiders | 0.25 % | ||||
| Shares Owned By Institutions | 84.04 % | ||||
| Number Of Shares Shorted | 718.04 K | ||||
| Price To Book | 5.13 X | ||||
| Price To Sales | 57.89 X | ||||
| Revenue | 12.76 M | ||||
| EBITDA | (165.69 M) | ||||
| Net Income | (160.27 M) | ||||
| Total Debt | 60 K | ||||
| Book Value Per Share | 4.11 X | ||||
| Cash Flow From Operations | (141.22 M) | ||||
| Short Ratio | 2.92 X | ||||
| Earnings Per Share | (2.21) X | ||||
| Target Price | 37.0 | ||||
| Number Of Employees | 62 | ||||
| Beta | -0.001 | ||||
| Market Capitalization | 2.29 B | ||||
| Total Asset | 347.1 M | ||||
| Retained Earnings | (316.97 M) | ||||
| Working Capital | 296.89 M | ||||
| Net Asset | 347.1 M |
About NewAmsterdam Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NewAmsterdam Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NewAmsterdam Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NewAmsterdam Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NewAmsterdam Stock Analysis
When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.